TUESDAY, May 17, 2022 (HealthDay News) — Vaccination against the virus that causes most cervical cancers has spurred a widespread reduction of infections among young Americans — including those who are unvaccinated, a new government study finds. The study, by the U.S. Centers for Disease Control and Prevention, looked atContinue Reading

MONDAY, April 25, 2022 (HealthDay News) — Two in five adults with attention-deficit/hyperactivity disorder say their mental health is excellent, which is significantly lower than people without the disorder, but still an encouraging finding, according to the authors of a new study. Their analysis of a Canadian government mental healthContinue Reading

WEDNESDAY, April 13, 2022 (HealthDay News) — Rates of gonorrhea are on the rise, and this sexually transmitted disease is becoming increasingly resistant to antibiotics, raising fears of a potential superbug. Luckily, while there isn’t a vaccine against gonorrhea yet, an available meningitis vaccine may offer some protection against thisContinue Reading

TUESDAY, April 12, 2022 (HealthDay News) — A single dose of human papillomavirus (HPV) vaccine provides as much protection against cervical cancer as the standard three-dose regimen, a new study finds. “These findings are a game-changer that may substantially reduce the incidence of HPV-attributable cervical cancer, and positions single-dose HPVContinue Reading

MONDAY, April 11, 2022 (HealthDay News) — Too few sexually active teens are getting tested for sexually transmitted diseases (STDs), according to a new report by U.S. health officials. In all, just 20% of sexually active high school students said they were tested for an STD — now called sexuallyContinue Reading

THURSDAY, April 7, 2022 (HealthDay News) — The introduction of HAART (highly active anti-retroviral therapy) in the mid-1990s revolutionized the treatment of HIV/AIDS, halting disease progression and dramatically extending lives. Now, a small new study suggests another potential use for one of the standard HAART medications: It halted disease progressionContinue Reading

MONDAY, March 28, 2022 (HealthDay News) — Certain antiviral drugs used to treat HIV may also guard against COVID-19 infection, a new study suggests. The researchers found that people with HIV who are on antiretroviral treatment (ART) with protease inhibitors may have a lower risk of COVID-19 infection. Protease inhibitorsContinue Reading

TUESDAY, March 8, 2022 (HealthDay News) — There are serious mental harms and high financial costs associated with so-called conversion therapy for LGBTQ people, researchers report. Conversion therapy attempts to make lesbian, gay, bisexual, transgender and queer people “straight.” Its safety and effectiveness has been discredited in multiple prior studies.Continue Reading